Previous reviews have identified that the DNA methylation patterns in lung cancer were altered, where genome-wide hypomethylation, and hypermethylation of the promoter regions of several tumor suppressor genes, such as DAPK, RASSF1A and RARβ, were commonly observed [106,107]. The gene discussed is RASSF1; the disease is lung carcinoma.